DUBLIN--(BUSINESS WIRE)--The "Global Drug Delivery Technology Market - Technologies, Market Share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
Drug delivery technology deals with release and transfer of a pharmaceutical drug to the body to achieve the health benefits. Global drug delivery technology market is expected to rise with the CAGR of about 7.1% during forecast period 2017-2024.
Growth in biologics industry contributes towards the growth of global drug delivery technology market during forecast period. However, side effects of drugs coupled with risk associated with needle stick injuries and product recalls and failures are some of the major factors restraining the growth of global drug delivery technology market during the forecast period. Increasing demand for generic drugs and biosimilars is one of the major opportunities whereas patent cliff and expiry acts as one of the challenges for global drug delivery technology market.
Geographically, global drug delivery technology market report has been segmented in North America, Asia Pacific, Europe, and Rest of the World. North America is expected to dominate global drug delivery technology market during the forecast period due to factors such as high prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, respiratory diseases, ongoing technological advancements in drug delivery technology, etc.
- 3M Company
- Antares Pharma, Inc.
- Bayer AG
- Becton, Dickinson And Company
- F. Hoffmann-La Roche Ltd.
- Generex Biotechnology
- Glaxosmithkline Plc
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Psivida Corporation
- Sanofi S.A.
- Vectura Group Plc
Key Topics Covered:
2. Market Overview
3. Market Determinants
4. Global Drug Delivery Technology Market By Route Of Administration
5. Global Drug Delivery Technology Market By Facility Of Use
6. Global Drug Delivery Technology Market By Stakeholders
7. Competitive Landscape
8. Geographic Analysis
9. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/hgs9xq/global_drug?w=4